This page will host Events plug-in for all Clarion and trade events.

Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

227.08 -0.42 (-0.18%)
Streaming Delayed Price Updated: 9:55 AM EDT, Apr 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 681,824
Open 225.77
Bid (Size) 227.04 (100)
Ask (Size) 227.14 (200)
Prev. Close 227.50
Today's Range 224.35 - 227.48
52wk Range 146.12 - 251.71
Shares Outstanding 2,628,679,824
Dividend Yield 2.29%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Is Bristol Myers Squibb the Best Bargain in Big Pharma? ↗
This pharma stock is cheap for a reason. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Small Cap or Megacap: Which Healthcare Stock Is Right for You? ↗
Healthcare companies with different market caps offer different rewards and challenges. 
Via The Motley Fool

Performance

YTD
+9.5%
+9.5%
1 Month
-5.6%
-5.6%
3 Month
+2.5%
+2.5%
6 Month
+19.3%
+19.3%
1 Year
+46.2%
+46.2%

More News

Read More
Top gainers and losers in the S&P500 index during Wednesday's after-hours session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Founders Capital Loads Up on Midstream Stock With $3.4 Million Buy, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Energy Regulatory Compliance
News headline image
Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut of CARTOSOUND SONATA, to Advance Arrhythmia Care at HRS 2026
From Johnson & Johnson
Via Business Wire
News headline image
3 Giant Dividend Stocks Raising Payouts With Yields Up to 4% ↗
Via MarketBeat
News headline image
Could This Healthcare Stock Help Make You Rich Over the Next Decade? ↗
Via The Motley Fool
News headline image
Is Johnson & Johnson a Buy After Its Q1 2026 Earnings Report? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Catalysts That Could Send Teva Stock to $40 and Beyond ↗
Via The Motley Fool
News headline image
3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist ↗
Via The Motley Fool
News headline image
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine ↗
Via The Motley Fool
News headline image
3 Healthcare Stocks That Have Held Up in Every Market Downturn ↗
Via The Motley Fool
Topics Economy
News headline image
Skip the 10-Year Bond? 3 Dividend Aristocrats to Consider Now ↗
Via MarketBeat
Topics Bonds Earnings Economy
News headline image
The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
From Equity Insider
Via GlobeNewswire
News headline image
Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson ↗
Via Benzinga
News headline image
Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
Via MarketMinute
Topics Economy Intellectual Property
News headline image
These Analysts Boost Their Forecasts On Johnson & Johnson Following Strong Q1 Results ↗
Via Benzinga
News headline image
Johnson & Johnson Posts Solid Q1 To Kickstart 'Year Of Accelerating Growth,' Says Bullish Analyst ↗
Via Benzinga
News headline image
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A
Via MarketMinute
Topics Economy
News headline image
Transcript: Johnson & Johnson Q1 2026 Earnings Conference Call ↗
Via Benzinga
News headline image
Oil Drops, Dimon Warns, and the Record Is Within Reach ↗
Via Chartmill
Topics Artificial Intelligence Economy Government
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
Via MarketMinute
Topics Bankruptcy Earnings Economy

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 227.08
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 04/27/26 09:55 AM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 596.92B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 597B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.